CTKB Stock Analysis: Buy, Sell, or Hold?
CTKB - Cytek Biosciences, Inc. Common Stock
$4.59
0.01 (0.22%)
▲
5d:
+2.68%
30d:
+9.55%
90d:
+2.46%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When CTKB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CTKB is 7.7% above its trading range ($4.26). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CTKB is 7.7% above its trading range ($4.26). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: CTKB is currently trading at $4.59, which is considered extended relative to its 30-day fair value range of $3.83 to $4.26. From a valuation perspective, the stock is trading at a discount (Forward PE: 24.2) compared to its historical average (62.6). Remarkably, the market is currently pricing in an annual earnings decline of 27.2% over the next few years. This pessimistic expectation contrasts with the company's recent 73.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CTKB is in a downtrend. The price is approaching resistance at $4.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CTKB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.69 (+23.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CTKB is in a downtrend. The price is approaching resistance at $4.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CTKB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.69 (+23.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.83 -
$4.26
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range (+7.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.9% below Wall St target ($5.69)
Trading Range Analysis
30-Day Trading Range
$3.83 -
$4.26
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.70
Resistance Level
$4.68
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.16
Wall Street Target
$5.69
(+23.9%)
Revenue Growth (YoY)
6.5%
Earnings Growth (YoY)
73.5%
Profit Margin
-36.2%
Valuation Discount vs History
-27.2% cheaper
PE vs Historical
24.2 vs 62.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-27.2%
(market-implied from PE analysis)
1-Year Target
$4.13
(-10%)
2-Year Target
$3.72
(-19%)
3-Year Target
$3.35
(-27%)
3-Yr Target (if PE normalizes)
(PE: 24→63)
$8.67
(+89%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.2 to 62.6
Stabilization Target:
$11.89
(+159.1%)
PE Expansion Potential:
+159.1%
Share & Embed Analysis
Last updated: July 03, 2026 1:40 AM ET
Data refreshes hourly during market hours. Next update: 2:40 AM
Data refreshes hourly during market hours. Next update: 2:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTKB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
